Intco Medical Technology Management

Management criteria checks 3/4

Intco Medical Technology's CEO is Qiong Chen, appointed in Jan 2015, has a tenure of 9.83 years. directly owns 0.067% of the company’s shares, worth CN¥11.26M. The average tenure of the management team and the board of directors is 6.1 years and 4.4 years respectively.

Key information

Qiong Chen

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	9.8yrs
CEO ownership	0.07%
Management average tenure	6.1yrs
Board average tenure	4.4yrs

Recent management updates

Recent updates

CEO

Qiong Chen (42 yo)

9.8yrs

Tenure

CN¥1,946,000

Compensation

Ms. Chen Qiong serves as General Manager and Director of Intco Medical Technology Co., Ltd. (formerly known as Shandong Intco Medical Products Co., Ltd.) Since January 2015, Ms. Chen has served in Intco Me...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Qiong Chen	GM & Director	9.8yrs	CN¥1.95m	0.067% CN¥ 11.3m
Feng Jie	Financial Director	6.1yrs	CN¥743.20k	0.042% CN¥ 7.1m
Li Bin	Secretary of the Board & Deputy GM	6.1yrs	CN¥928.10k	no data
Hai Sheng Yu	Deputy GM & Non-Independent Director	no data	CN¥1.41m	0.036% CN¥ 6.1m
Ye Tang	Chairman of the Board of Supervisors	no data	no data	no data

6.1yrs

Average Tenure

41yo

Average Age

Experienced Management: 300677's management team is seasoned and experienced (6.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Qiong Chen	GM & Director	9.8yrs	CN¥1.95m	0.067% CN¥ 11.3m
Hai Sheng Yu	Deputy GM & Non-Independent Director	6.1yrs	CN¥1.41m	0.036% CN¥ 6.1m
Ye Tang	Chairman of the Board of Supervisors	14.6yrs	no data	no data
Fang Yi Liu	Chairman of the Board	9.6yrs	CN¥3.20m	36.11% CN¥ 6.1b
Jing Sun	Non-Independent Director	9.6yrs	CN¥1.31m	no data
Juan Xu	Non-Employee Supervisor	2.7yrs	no data	no data
Yang Wang	Independent Director	2.7yrs	CN¥134.00k	no data
Xiaohui Wu	Independent Director	2.7yrs	CN¥134.00k	no data
Jing Xiang	Independent Director	2.7yrs	CN¥134.00k	no data
Wenning Di	Employee Supervisor	2.7yrs	no data	0.0011% CN¥ 192.2k

4.4yrs

Average Tenure

46.5yo

Average Age

Experienced Board: 300677's board of directors are considered experienced (4.4 years average tenure).

Intco Medical Technology Management

Management criteria checks 3/4

Key information

Recent management updates

Intco Medical Technology Co., Ltd., Annual General Meeting, May 16, 2024

High number of new directors

High number of new directors

Intco Medical Technology Co., Ltd., Annual General Meeting, Apr 08, 2021

Recent updates

Intco Medical Technology Co., Ltd. Announces Interim Profit Distribution Plan (A Shares) for 2024, Payable on 31 October 2024

Investor sentiment improves as stock rises 23%

Intco Medical Technology Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Intco Medical Technology Co., Ltd. (SZSE:300677) announces an Equity Buyback for CNY 120 million worth of its shares.

Intco Medical Technology Co., Ltd. Approves Interim Profit Distribution Plan for 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 22%

Intco Medical Technology Co., Ltd. Proposes Interim Dividend for First Half of 2024

Second quarter 2024 earnings released: EPS: CN¥0.54 (vs CN¥0.67 in 2Q 2023)

Investor sentiment deteriorates as stock falls 18%

Intco Medical Technology Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Dividend reduced to CN¥0.08

Intco Medical Technology Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 31 May 2024

Intco Medical Technology Co., Ltd., Annual General Meeting, May 16, 2024

Full year 2023 earnings released: EPS: CN¥0.58 (vs CN¥0.95 in FY 2022)

Intco Medical Technology Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Intco Medical Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: CN¥0.058 (vs CN¥0.36 in 3Q 2022)

Intco Medical Technology Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023

Second quarter 2023 earnings released: EPS: CN¥0.67 (vs CN¥0.49 in 2Q 2022)

Intco Medical Technology Co., Ltd. (SZSE:300677) announces an Equity Buyback for CNY 200 million worth of its shares.

First quarter 2023 earnings released: CN¥0.23 loss per share (vs CN¥0.13 profit in 1Q 2022)

Investor sentiment deteriorates as stock falls 16%

Investor sentiment deteriorated over the past week

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.36 (vs CN¥1.73 in 3Q 2021)

High number of new directors

Intco Medical Technology Co., Ltd. (SZSE:300677) announces an Equity Buyback for CNY 500 million worth of its shares.

Intco Medical Technology Co., Ltd. Approves Cash Dividend for the Year 2021

Intco Medical Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥7.24 in 1Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥2.08 (vs CN¥5.04 in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥5.55 (vs CN¥5.50 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥10.86 (vs CN¥0.44 in 1Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Intco Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2020

Full year 2020 earnings released: EPS CN¥21.98 (vs CN¥0.61 in FY 2019)

Intco Medical Technology Co., Ltd., Annual General Meeting, Apr 08, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

New 90-day high: CN¥284

Intco Medical Technology Co., Ltd. to Report Fiscal Year 2020 Results on Mar 15, 2021

Investor sentiment improved over the past week

Intco Medical Technology Co., Ltd. announced that it has received CNY 499.999981 million in funding

New 90-day high: CN¥188

New 90-day high: CN¥149

Market bids up stock over the past week

Market pulls back on stock over the past week

Market bids up stock over the past week

New 90-day high: CN¥118

Third quarter earnings released

Market bids up stock over the past week

First half earnings released

Intco Medical Technology Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

Tenure

Compensation

Leadership Team

Average Tenure